Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF): Results From the Advanced Gastric Cancer Expansion Cohort.
Kohei ShitaraMotohiro HiraoSatoru IwasaTakashi OshimaYoshito KomatsuAkihito KawazoeYasuyoshi SatoTakuya HamakawaKan YonemoriNozomu MachidaSatoshi YukiTakuya SuzukiShiori OkumuraTakao TakaseTaro SembaBob ZimmermannAngela TengKensei YamaguchiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
gov registration: NCT03207672.